Terran Biosciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $100M

  • Investors
  • 20

Terran Biosciences General Information

Description

Developer of a biotechnology platform designed to advance transformative therapeutics and technologies for neurological and psychiatric diseases. The company offers late-stage therapies for schizophrenia and serotonin 2A receptor antagonists, a proprietary drug design engine for psychedelic therapies, and AI-enabled imaging software, enabling patients with neurological and psychiatric conditions to achieve improved treatment outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Miami Beach, FL
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Corporate Office
  • Miami Beach, FL
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Terran Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 14-Apr-2022 $100M Completed Generating Revenue
4. Early Stage VC 01-Feb-2021 Completed Generating Revenue
3. Seed Round 22-May-2020 Completed Generating Revenue
2. Seed Round 03-Oct-2019 $9.4M $10.8M Completed Generating Revenue
1. Seed Round 01-Jan-2019 $1.4M $1.4M Completed Generating Revenue
To view Terran Biosciences’s complete valuation and funding history, request access »

Terran Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
To view Terran Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Terran Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to advance transformative therapeutics and technologies for neurological
Biotechnology
Miami Beach, FL
6 As of 2022

Geneva, Switzerland
 

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Terran Biosciences Competitors (6)

One of Terran Biosciences’s 6 competitors is Neurosterix, a Venture Capital-Backed company based in Geneva, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurosterix Venture Capital-Backed Geneva, Switzerland
Neumora Formerly VC-backed Watertown, MA
Definium Therapeutics Formerly VC-backed New York, NY
COMPASS Pathways Formerly VC-backed Altrincham, United Kingdom
GH Research Formerly VC-backed Dublin, Ireland
To view Terran Biosciences’s complete competitors history, request access »

Terran Biosciences Patents

Terran Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025174424-A1 Analogs of xanomeline, analogs of trospium, and methods of use thereof Pending 16-Feb-2024
US-12269818-B2 Analogs of xanomeline Active 24-Apr-2023
US-20240368149-A1 Analogs of xanomeline Active 24-Apr-2023
AU-2024263007-A1 Prodrugs of xanomeline, prodrugs of trospium and methods of use thereof Pending 24-Apr-2023
EP-4705289-A1 Prodrugs of xanomeline, prodrugs of trospium and methods of use thereof Pending 24-Apr-2023 C07D417/04
To view Terran Biosciences’s complete patent history, request access »

Terran Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Terran Biosciences Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brkfst Club Venture Capital Minority
Manta Capital Advisors Venture Capital Minority
Nettle Ventures Venture Capital Minority
Angel (individual) Minority
Astir Ventures Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Terran Biosciences Investments (2)

Terran Biosciences’s most recent deal was a Corporate Asset Purchase with Blumentech (Patent Portfolio and Accompanying Data). The deal was made on 13-Apr-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Blumentech (Patent Portfolio and Accompanying Data) 13-Apr-2022 Corporate Asset Purchase Buildings and Property
Concert Pharmaceuticals (Portfolio Central Nervous System Assets) 11-Mar-2022 Corporate Asset Purchase Pharmaceuticals
To view Terran Biosciences’s complete investments history, request access »

Terran Biosciences Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Concert Pharmaceuticals (Portfolio Central Nervous System Assets) Lexington, MA

Terran Biosciences FAQs

  • When was Terran Biosciences founded?

    Terran Biosciences was founded in 2017.

  • Where is Terran Biosciences headquartered?

    Terran Biosciences is headquartered in Miami Beach, FL.

  • What is the size of Terran Biosciences?

    Terran Biosciences has 6 total employees.

  • What industry is Terran Biosciences in?

    Terran Biosciences’s primary industry is Biotechnology.

  • Is Terran Biosciences a private or public company?

    Terran Biosciences is a Private company.

  • What is the current valuation of Terran Biosciences?

    The current valuation of Terran Biosciences is .

  • What is Terran Biosciences’s current revenue?

    The current revenue for Terran Biosciences is .

  • How much funding has Terran Biosciences raised over time?

    Terran Biosciences has raised $113M.

  • Who are Terran Biosciences’s investors?

    Brkfst Club, Manta Capital Advisors, Nettle Ventures, , and Astir Ventures are 5 of 20 investors who have invested in Terran Biosciences.

  • Who are Terran Biosciences’s competitors?

    Neurosterix, Neumora, Definium Therapeutics, COMPASS Pathways, and GH Research are some of the 6 competitors of Terran Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process